Articles On Orthocell (ASX:OCC)

Remember Orthocell (ASX: OCC), that company gained 377 per cent in a day when it showed Cel-Gro helped patients with nerve damage regain sensation? It could be even more powerful than it showed then. While indeed, the trial showed it helpe...

Orthocell (ASX: OCC) published yet another batch of trial results relating to CelGro which it says validates its claim that the technique can deliver higher quality nerve repair compared to existing methods. Earlier this morning, the regene...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Regenerative medicine company Orthocell (ASX:OCC) has announced positive pre-clinical results for the use of CelGro in enhancing repair of severed peripheral nerves.

When your stock crashes you have three options: run away (and wait to claim the tax loss), sit still and hope things get better or ‘top up’. Speedcast’s (ASX: SDA) Peter Jackson bought $144,000 last week only a few weeks after it crashed. M...

Here’s one that investors can really get their teeth into: Orthocell’s (ASX:OCC) regenerative therapy Celgro quickens and improves dental implant procedures and repairs jangled nerves in more ways than one. To the joy of Collingwood support...

At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success...

The Australian economy, like many countries, is facing challenges in terms of an ageing population, rising chronic diseases, rising demand for new treatments and more hospital beds. S&P/ASX 200 Health Care Index generated an annual retu...

The positive data comes as Orthocell is active in partnering discussions and will support the company to gain traction in key markets.

CV Check Ltd CV Check Ltd (ASX: CV1) is a leading online integrated screening and verification company which offers check products to employers, industry associations and individual customers through the CVCheck brand on its proprietary web...

Orthocell (ASX: OCC) has achieved a substantial reduction in dental implant treatment timeframes during a study using its CelGro regeneration device which facilitates bone and tissue repair and healing. During a single stage dental implant...

Shares in grow-your-own-bone biotech Orthocell (ASX:OCC) are up after it proved, once again, that we live in science fiction times. Today the company said all 10 patients in a dental bone regeneration study had successfully grown enough new...

It’s only a couple of weeks until the end of financial year and some people take steps to minimise their tax. One is selling shares they have made a capital loss on, using them to offset any capital gains. But how can you tell which one are...